Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Selective alpha4beta7 integrin inhibitors and their use described by Japanese lab

Sep. 6, 2001

Antiviral effect seen for rhIL-12 monotherapy in pilot trial in patients with chronic HCV

Sep. 6, 2001

Medivir and Chiron establish collaboration for novel HCV drugs

Sep. 5, 2001

Metabasis receives SBIR grant for hepatitis B prodrug development

Sep. 4, 2001

Sanofi-Synthelabo claims new series of beta3-adrenoceptor agonists

Sep. 3, 2001

JT describes new agents for hepatitis C

Sep. 3, 2001

Mitsubishi highlights their anti-H. pylori candidate at the ACS meeting

Aug. 31, 2001

Salix acquires rights to Colazal for Japan, Korea and Taiwan

Aug. 31, 2001

A promising scaffold for bioartificial liver development

Aug. 29, 2001

Helivax demonstrates safety, immunogenicity in phase Ib trial

Aug. 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.